| Current dividend yield | 2.49 % |
| Dividendenrendite 5 Jahre | 7.31 % |
| Dividend Yield 10Y | 8.29 % |
| Payout 3Y | 5.83 % |
Regeneron Pharmaceuticals pays the next dividend on Dec 03 2026 (payday). The ex-day is on Nov 20 2026. The Regeneron Pharmaceuticals stock dividend is paid 4 times a year. In order to receive a dividend, you should generally own the Regeneron Pharmaceuticals stock before the ex-dividend date. The Dividend Calendar shows that the last ex-day dates were February, May, August and November . Dividends from Regeneron Pharmaceuticals are distributed via March, June, August and December.
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2026 |
$0.94
Forecast
$0.94
Forecast
|
Nov 20 2026
Nov 20 2026
Dec 03 2026
Nov 20 26
Dec 03 26 |
Dec 03 2026 |
quarterly
quarterly
|
| 2026 |
$0.94
$0.94
|
Aug 18 2026
Aug 18 2026
Aug 31 2026
Aug 18 26
Aug 31 26 |
Aug 31 2026 |
quarterly
quarterly
|
| 2026 |
$0.94
$0.94
|
May 20 2026
May 20 2026
Jun 04 2026
May 20 26
Jun 04 26 |
Jun 04 2026 |
quarterly
quarterly
|
| 2026 |
$0.94
$0.94
|
Feb 20 2026
Feb 20 2026
Mar 05 2026
Feb 20 26
Mar 05 26 |
Mar 05 2026 |
quarterly
quarterly
|
| 2025 |
$0.88
$0.88
|
Nov 20 2025
Nov 20 2025
Dec 05 2025
Nov 20 25
Dec 05 25 |
Dec 05 2025 |
quarterly
quarterly
|
| 2025 |
$0.88
$0.88
|
Aug 18 2025
Aug 18 2025
Sep 03 2025
Aug 18 25
Sep 03 25 |
Sep 03 2025 |
quarterly
quarterly
|
| 2025 |
$0.88
$0.88
|
May 20 2025
May 20 2025
Jun 06 2025
May 20 25
Jun 06 25 |
Jun 06 2025 |
quarterly
quarterly
|
| 2025 |
$0.88
$0.88
|
Feb 20 2025
Feb 20 2025
Mar 20 2025
Feb 20 25
Mar 20 25 |
Mar 20 2025 |
-
-
|
Regeneron Pharmaceuticals most recently paid a dividend of $0.94. Regeneron Pharmaceuticals paid a Dividend of $3.76 Per Share in the financial year 2026. With a stock price of $945.53 at Nov 18 2026, the current dividend yield is 0.40% (calculation: $3.76 / $945.53 = 0.40%). No special dividend was paid.
The average Regeneron Pharmaceuticals dividend yield over the last 5 years is 0.19% and the average over the last 10 years is 0.12%.
The payout ratio of Regeneron Pharmaceuticals in relation to the last financial year is 8.49%. The payout ratio smoothed over 3 years is 3.07%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Regeneron Pharmaceuticals |
|---|---|
| Current dividend yield | 0.40% |
| Dividend Yield 5Y | 0.19% |
| Dividend Yield 10Y | 0.12% |
| Payout 1Y | 8.49% |
| Payout 3Y | 3.07% |
Regeneron Pharmaceuticals has been paying a dividend for 2 years and has not lowered the dividend for 2 years (dividend continuity). As a result, the dividend was recently increased 2-times.
The Dividend Growth in relation to the previous financial year amounts to 6.82%.
| Metric | Regeneron Pharmaceuticals |
|---|---|
| Increased | 2 Years |
| Continuity | 2 Years |
| Paid | 2 Years |
| Growth 1Y | 6.82% |
Regeneron Pharmaceuticals has been paying a dividend for 2 years and has not lowered the dividend for 2 years (dividend continuity). As a result, the dividend was recently increased 2-times.
The Dividend Growth in relation to the previous financial year amounts to 6.82%.
On the stock exchange, the Regeneron Pharmaceuticals stock (ISIN: US75886F1075) is not traded as a top scorer in November 2026 according to the dividend strategy.
The stock price of Regeneron Pharmaceuticals 22.50% has risen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Regeneron Pharmaceuticals stock price in real time at the top of the page.
Regeneron Pharmaceuticals (symbol: REGN) is valued at a Price / Earnings Ratio (P/E ratio) of 20.73 and a price/sales ratio (P/S ratio) of 5.79 valued. Based on analyst estimates, the Regeneron Pharmaceuticals stock forecast 2026 of the current financial year corresponds to a valuation of 13.46 according to P/E ratio and 5.10 according to P/S.
| Metric | Regeneron Pharmaceuticals |
|---|---|
| Dividend Score | ??/15 |
| Performance 2026 |
22.50%
|
| P/E TTM | 20.73 |
| P/S TTM | 5.79 |
| P/E forward | 13.46 |
| P/S forward | 5.10 |
Regeneron Pharmaceuticals (symbol: REGN) is valued at a Price / Earnings Ratio (P/E ratio) of 20.73 and a price/sales ratio (P/S ratio) of 5.79 valued. Based on analyst estimates, the Regeneron Pharmaceuticals stock forecast 2026 of the current financial year corresponds to a valuation of 13.46 according to P/E ratio and 5.10 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


